{"TopicDetails": {"type": 0, "ccm2Id": 44835229, "cftId": 0, "identifier": "EU4H-2022-PJ-05", "title": "Call for proposals to support increased capacity of notified bodies for medical devices", "publicationDateLong": 1644883200000, "callIdentifier": "EU4H-2022-PJ", "callTitle": "Action Grants 2022 - first wave", "callccm2Id": 44774006, "allowPartnerSearch": true, "workProgrammepart": {"id": 6515, "ccm_id": 45114455, "wp_part": "EU4H-2022", "wp_year": "EU4H-2022", "wp_title": "EU4H-2022"}, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 43332657, "abbreviation": "Health", "description": "Improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases"}, {"id": 43332653, "abbreviation": "EU4H-1", "description": "EU4H-1"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "22 February 2022", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["24 May 2022"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3382182": [{"action": "EU4H-2022-PJ-08 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 300000}, "budgetTopicActionMap": {}}], "3382184": [{"action": "EU4H-2022-PJ-05 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 4000000}, "budgetTopicActionMap": {}}], "3382186": [{"action": "EU4H-2022-PJ-04 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 1000000}, "budgetTopicActionMap": {}}], "3382188": [{"action": "EU4H-2022-PJ-01 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 30000000}, "budgetTopicActionMap": {}}], "3382190": [{"action": "EU4H-2022-PJ-02 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 5000000}, "budgetTopicActionMap": {}}], "3382192": [{"action": "EU4H-2022-PJ-07 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 30000000}, "budgetTopicActionMap": {}}], "3382194": [{"action": "EU4H-2022-PJ-06 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 29000000}, "budgetTopicActionMap": {}}], "3382196": [{"action": "EU4H-2022-PJ-03 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 8000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2022"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p><strong><span><span><span style=\"color:black\">Background and policy context</span></span></span></strong></p><p><span><span><span style=\"color:black\">The MDR and IVDR greatly rely on the capacity of notified bodies to certify such products, ensuring the placing on the market of devices compliant with the high level of safety and performance standard set out in the legislation. If notified bodies\u2019 capacity falls short, the key objective of the legislation to secure access and availability of safe and performant devices to the health sector and ultimately to patients in the Union is jeopardised. There is therefore a need to increase capacity of notified bodies to secure a proper and smooth application of the legislation especially in IVDs, which is largely composed by SMEs and where the new Regulation identifies many new essential tasks to be performed by notified bodies with specialised expertise. </span></span></span></p><p><span><span><span style=\"color:black\">The limited capacity of notified bodies currently represents a bottleneck for those market operators that are ready to implement the Regulations but unable to find notified bodies available to certify their devices. On the other hand, several market operators have shown poor preparedness and incur delays to adapt to the high-level standards set up by the Regulations which has increased the expected time spent by notified bodies to certify such medical devices. In summary, the current situation raises serious concerns about potential risk of shortages and disruption of supply of devices, especially critical IVDs. </span></span></span></p><p><span><span><span style=\"color:black\">This action supports the policy priority to respond to support the implementation of the legislation and implements the EU4Health Programme\u2019s general objective of strengthening health systems (Article 3, point (d)) through the specific objectives defined in Article 4, points (h) and (i), of Regulation (EU) 2021/522.</span></span></span></p>\n<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p><strong><span><span><span style=\"color:black\">Objectives pursued </span></span></span></strong></p><p><span><span><span style=\"color:black\">This action will contribute to addressing serious concerns about the lack of availability of vital devices in the medium to long term by increasing capacity of notified bodies and preparedness of market operators, in particular SMEs, with a particular focus on IVDs.</span></span></span></p><p><strong><span><span><span style=\"color:black\">Description of the activities to be funded under this topic</span></span></span></strong></p><p><span><span><span style=\"color:black\">a) Supporting training, coaching and internship activities addressed to medical devices\u2019 notified bodies as well as third-party entities (conformity assessment bodies) on the process to become a notified body for medical devices;a) Supporting training, coaching and internship activities addressed to medical devices\u2019 notified bodies as well as third-party entities (conformity assessment bodies) on the process to become a notified body for medical devices; </span></span></span></p><p><span><span><span style=\"color:black\">b) Capacity building activities such as webinars, workshops, targeted feedback and informative sessions addressed to market operators; </span></span></span></p><p><span><span><span style=\"color:black\">c) Appraisal of the certification demand, with the objective to identify the types of devices for which availability of notified bodies is particularly low or lacking; </span></span></span></p><p><span><span><span style=\"color:black\">d) Proposing solutions to facilitate matching the demand of market operators with the availability of notified bodies, in particular in the area of IVDs where SMEs are prominent.</span></span></span></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><strong><span><span><span style=\"color:black\">Expected results and impact</span></span></span></strong></p><p><span><span><span style=\"color:black\">The action is expected to increase the capacity of notified bodies, increase preparedness of market operators in particular in the area of IVDs (including SMEs) and facilitating the match of demand from the market with the availability of capacity in notified bodies. This ultimately will contribute to secure availability of safe and performant devices in the best interest public health and patients\u2019 safety in Union, thus safeguarding essential objectives of the new regulatory framework.</span></span></span></p><p><strong><span><span><span style=\"color:black\">Specific mandatory deliverables and/or milestones</span></span></span></strong></p><p><span><span><span style=\"color:black\">For the purpose of this action, medical devices shall be understood as medical devices and <em>in vitro</em> diagnostics medical devices, as defined in Article 2(1) of Regulation (EU) 2017/745 and Article 2(2) of Regulation (EU) 2017/746, respectively, unless otherwise specified. </span></span></span></p><p><span><span><span style=\"color:black\">The applicants should provide the following deliverables: </span></span></span></p><ul level=\"0\"><li><span><span><span>For the activities related to point (a) and (b) of section C as above: at least two training sessions/year; in addition, for point (b) min number of participants 50.</span></span></span></li><li><span><span><span>For point (a), market analysis to create a list of existing and potential new notified bodies (public or private) interested to receiving the training, coaching and internships; this list has to be kept up-to date for the all duration of the action. </span></span></span></li><li><span><span><span>For point a) the internship activity has to be conducted at the manufacturer premises in order to increase the capacity building of existing and potential new notified bodies. </span></span></span></li><li><span><span><span>For point (c), a manufacture\u2019s survey should be carried out as soon as the action starts, ensuring a broad coverage of manufacturers placing medical devices on the EU market. In particular, the survey has to ensure inclusion of both EU and non-EU manufacturers, big companies as well as SMEs and should cover all the different types of medical devices (see devices codes listed in <a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R2185&amp;from=EN\">Regulation 2017/2185</a>). An update of the survey (or more if needed) should be launched throughout the duration of this action. </span></span></span></li><li><span><span><span>For (d), a proposed mechanism for notified bodies to provide updated information (to be kept as confidential) on their availability to certify medical devices in particular for <em>in vitro</em> diagnostics devices. This mechanism needs to be tested within the three months after the action starts. </span></span></span></li> </ul><p> <strong><span><span><span style=\"color:black\">Specific action-level indicators for reporting purposes</span></span></span></strong></p><p><span><span><span style=\"color:black\">Applicants must be prepared to include data on the following specific action-level indicators in their regular reporting activities in case of award:</span></span></span></p><ul level=\"0\"><li><span><span><span>List of EU and non-EU manufacturers identified, by size, by action of involvement and branch of activities described in section C (a) to (c)</span></span></span></li><li><span><span><span>Number of existing and potential new notified bodies involved by branch of activities described in section C. </span></span></span></li><li><span><span><span>Number of training, coaching and internship session developed</span></span></span></li><li><span><span><span>Number of people and entities attending to the capacity building activities </span></span></span></li><li><span><span><span>Number of new potential notified bodies on medical devices in accordance with MDR and IVDR. </span></span></span></li><li><span><span><span>Number of certifications requests received by the notified bodies. </span></span></span></li><li> <p><span><span><span style=\"color:black\">The applicants are required to include in their proposals additional specific action-level indicators which will be agreed with the Commission during the grant agreement preparation.</span></span></span></p> </li> </ul><p><span><span><span style=\"color:black\">The Commission may require the awardees to collect data for additional specific action-level indicators, where needed to complement the above indicators.</span></span></span></p>\n", "conditions": "<p><b><span style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\" lang=\"EN-US\">Conditions<br />\r\n</span></b></p>\r\n<p><b><span style=\"color:#404040;mso-themecolor:&#xA;text1;mso-themetint:191;mso-ansi-language:EN-US\" lang=\"EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\"> call document</a></span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<ul>\r\n    <li><b><span style=\"color: rgb(64, 64, 64);\" lang=\"EN-US\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a> and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<p><b><span style=\"color: rgb(64, 64, 64);\" lang=\"EN-US\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\" lang=\"EN-US\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#xA;mso-ansi-language:EN-US\" lang=\"EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#xA;mso-ansi-language:EN-US\" lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p><strong>EU4health standard application form</strong>:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\">Standard application form</a><br />\r\n<strong>EU4Health detailed budget</strong>:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/reference-documents;programCode=EU4H\" target=\"_blank\">EU4Health Detailed budget table</a><br />\r\n<strong>EU4Health Programme</strong>:&nbsp;<a href=\"https://ec.europa.eu/health/funding/eu4health_en\" target=\"_blank\">EU4Health programme</a><br />\r\n<strong>EU4Health</strong>:&nbsp;<a href=\"https://ec.europa.eu/health/publications/2022-eu4health-work-programme_en\" target=\"_blank\">2022 Annual Work Programme</a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><strong>EU4Health programme:</strong> <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\">EU4Health&nbsp; MGA v1.0</a><br />\r\n<strong>EU4Health Regulation</strong>:  <a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\">Regulation 2021/522</a><br />\r\n<strong>EU financial Regulation</strong>: <a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" target=\"_blank\">EU Financial Regulation 2018/1046</a></p>\r\n<p>&nbsp;</p>", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\"> </span>HaDEA-HP-CALLS@ec.europa.eu </p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "", "staticAdditionalInfo": "", "latestInfos": [{"approvalDate": "Oct 26, 2022 11:41:37 AM", "lastChangeDate": "Oct 26, 2022 11:41:37 AM", "content": "<p class=\"MsoNormal\"><span style=\"font-size:10.5pt;line-height:115%;font-family:&#10;&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:&#10;Arial;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">A total of 41 </span><b><span style=\"font-size:10.5pt;line-height:115%;font-family:&quot;inherit&quot;,serif;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Helvetica;&#10;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">proposals have been submitted&nbsp;</span></b><span style=\"font-size:10.5pt;line-height:115%;&#10;font-family:&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-font-family:Arial;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:EN-IE\">in response to this call.</span><span lang=\"EN-GB\"><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-01: 6 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-02: 5 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-03: 6 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-04: 4 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-05: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-06: 17 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-07: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-08: 1 proposal<o:p></o:p></span></p>"}, {"approvalDate": "Feb 22, 2022 12:00:08 AM", "lastChangeDate": "Feb 22, 2022 12:00:08 AM", "content": "The submission session is now available for: EU4H-2022-PJ-06(EU4H-PJG), EU4H-2022-PJ-02(EU4H-PJG), EU4H-2022-PJ-03(EU4H-PJG), EU4H-2022-PJ-01(EU4H-PJG), EU4H-2022-PJ-05(EU4H-PJG), EU4H-2022-PJ-08(EU4H-PJG), EU4H-2022-PJ-04(EU4H-PJG), EU4H-2022-PJ-07(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}